Elevated circulating SAA levels are consistently observed in conditions with a low-grade inflammatory component, such as in atherosclerosis, diabetes and obesity and are associated with increased risk of clinical coronary events (10, 11). The gene discussed is SAA2; the disease is obesity due to melanocortin 4 receptor deficiency.